Supplemental material
Journal of Market Access & Health Policy
Volume 6, 2018 - Issue 1
Open access
906
Views
4
CrossRef citations to date
0
Altmetric
Original Research Article
Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK
Zalmai HakimiMedical Affairs Department, Astellas Pharma Europe B.V, Leiden, The NetherlandsCorrespondence[email protected]
View further author information
, View further author information
Con KelleherDepartment of Obstetrics and Gynecology, Guy’s and St. Thomas’ NHS Foundation Trust, London, UKView further author information
, Samuel AballéaHealth Economics and Outcomes Research Department, Creativ-Ceutical SARL, Paris, FranceView further author information
, Khaled MamanHealth Economics and Outcomes Research Department, Creativ-Ceutical Ltd, London, UKView further author information
, Jameel NazirMedical Affairs Department, Astellas Pharma Europe Ltd, Chertsey, UKView further author information
, Colette MankowskiMedical Affairs Department, Astellas Pharma Europe Ltd, Chertsey, UKView further author information
& Isaac OdeyemiMedical Affairs Department, Astellas Pharma Europe Ltd, Chertsey, UKView further author information
show all
Article: 1438721
|
Received 20 Oct 2017, Accepted 30 Jan 2018, Published online: 20 Mar 2018
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.